title: Role of RYR3 splice variants in calcium signaling in mouse nonpregnant and pregnant myometrium.
abstract: Alternative splicing of ryanodine receptor subtype 3 (RYR3) may generate a short isoform (RYR3S) without channel function and a functional full-length isoform (RYR3L). The RYR3S isoform has been shown to negatively regulate the native RYR2 subtype in smooth muscle cells as well as the RYR3L isoform when both isoforms were coexpressed in HEK-293 cells. Mouse myometrium expresses only the RYR3 subtype, but the role of RYR3 isoforms obtained by alternative splicing and their activation by cADP-ribose during pregnancy have never been investigated. Here, we show that both RYR3S and RYR3L isoforms are differentially expressed in nonpregnant and pregnant mouse myometrium. The use of antisense oligonucleotides directed against each isoform indicated that only RYR3L was activated by caffeine and cADP-ribose in nonpregnant myometrium. These RYR3L-mediated Ca(2+) releases were negatively regulated by RYR3S expression. At the end of pregnancy, the relative expression of RYR3L versus RYR3S and its ability to respond to cADP-ribose were increased. Therefore, our results suggest that physiological regulation of RYR3 alternative splicing may play an essential role at the end of pregnancy.
authors.affiliation: Centre de Neurosciences Intégratives et Cognitives, UMR5228 CNRS, Université Bordeaux 1 and Université Bordeaux 2, Ave. des Facultés, Talence 33405, France. jlucmorel.cnic@voila.fr
authors.forename: Fabrice
authors.initials: F
authors.lastname: Dabertrand
authors.forename: Nicolas
authors.initials: N
authors.lastname: Fritz
authors.forename: Jean
authors.initials: J
authors.lastname: Mironneau
authors.forename: Nathalie
authors.initials: N
authors.lastname: Macrez
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Morel
mesh_terms: D017398:Alternative Splicing / Q000502:physiology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology*; D036563:Cyclic ADP-Ribose / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D051379:Mice; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000378:metabolism*; D009215:Myometrium / Q000166:cytology*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics* / Q000378:metabolism
chemical_list: D016376:Oligonucleotides, Antisense; D010726:Phosphodiesterase Inhibitors; D019837:Ryanodine Receptor Calcium Release Channel; D036563:Cyclic ADP-Ribose; D002110:Caffeine; D002118:Calcium